Immucor Acquires BioArray Solutions
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
TM Capital advised Immucor, Inc. (NASDAQ) on its $117 million acquisition of BioArray Solutions Ltd.
TM Capital served as financial advisor to DCN Dx in connection with a growth equity investment from Martis Capital
TM Capital, together with Pegasus Capital, served as a financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences
TM Capital served as exclusive financial advisor to Neoteryx, LLC in connection with its sale to Trajan Group Holdings Limited (Australian Stock Exchange: TRJ)